• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

10 年 CTEPH 治疗成功案例:打破罕见病的神话。

10-year success story in CTEPH treatment: breaking the myth of rareness.

机构信息

Internal Medicine Department, Centro Hospitalar Universitario de Santo Antonio, Porto, Portugal

Internal Medicine Department; Pulmonary Vascular Disease Unit, Centro Hospitalar Universitario de Santo Antonio, Porto, Portugal.

出版信息

BMJ Case Rep. 2024 Feb 6;17(2):e257942. doi: 10.1136/bcr-2023-257942.

DOI:10.1136/bcr-2023-257942
PMID:38320818
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10860018/
Abstract

Unlike acute pulmonary embolism (PE), the resolution of thrombi is ineffective in chronic thromboembolic pulmonary hypertension (CTEPH), leading to reorganisation and fibrotic changes within the pulmonary arteries. The authors report the case of a man in his 60s with polycythemia vera, under warfarin, following an acute PE. He was admitted a year later with right heart failure and haemodynamic instability. Acute over chronic PE caused this severe presentation, confirmed by right heart catheterisation and pulmonary scintigraphy. The challenging diagnosis and management involved transfer to a centre specialised in pulmonary vascular disease. Normalisation of functional and haemodynamic parameters, sustained in 10-year follow-up, was achieved with anticoagulation and triple therapy with prostanoids as a bridge to pulmonary thromboendarterectomy. Targeted medical therapy, not standard at that time, was crucial to recovering conditions for transfer. An individualised approach, integrating multidisciplinary pulmonary hypertension expertise, provides the basis for the best care for CTEPH.

摘要

与急性肺栓塞(PE)不同,慢性血栓栓塞性肺动脉高压(CTEPH)中的血栓溶解效果不佳,导致肺动脉内出现重构和纤维化改变。作者报告了一例 60 多岁的男性病例,该患者患有真性红细胞增多症,正在服用华法林,曾因急性 PE 住院。一年后,他因右心衰竭和血流动力学不稳定再次入院。急性 PE 加重慢性 PE 导致了这种严重的表现,这一诊断在右心导管检查和肺闪烁扫描中得到了证实。由于涉及到转移到专门治疗肺血管疾病的中心,因此诊断和管理具有挑战性。在 10 年的随访中,通过抗凝和前列腺素类药物三联治疗作为肺血栓内膜切除术的桥梁,实现了功能和血流动力学参数的正常化,并得以维持。当时并未采用标准治疗方法的靶向药物治疗对于病情的恢复和转移至关重要。个体化的治疗方法,整合了多学科肺动脉高压专业知识,为 CTEPH 的最佳治疗提供了基础。

相似文献

1
10-year success story in CTEPH treatment: breaking the myth of rareness.10 年 CTEPH 治疗成功案例:打破罕见病的神话。
BMJ Case Rep. 2024 Feb 6;17(2):e257942. doi: 10.1136/bcr-2023-257942.
2
Prevalence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism. Prevalence of CTEPH after pulmonary embolism.急性肺栓塞后慢性血栓栓塞性肺动脉高压的患病率。肺栓塞后慢性血栓栓塞性肺动脉高压的患病率。
Thromb Haemost. 2014 Sep 2;112(3):598-605. doi: 10.1160/TH13-07-0538. Epub 2014 Jun 5.
3
Clinical Updates on the Diagnosis and Management of Chronic Thromboembolic Pulmonary Hypertension.慢性血栓栓塞性肺动脉高压的诊断与治疗临床进展。
Ann Acad Med Singap. 2020 May;49(5):320-330.
4
Chronic thromboembolic pulmonary hypertension from the perspective of patients with pulmonary embolism.从肺栓塞患者的角度看慢性血栓栓塞性肺动脉高压。
J Thromb Haemost. 2018 Jun;16(6):1040-1051. doi: 10.1111/jth.14016. Epub 2018 May 8.
5
Derivation of a clinical prediction score for chronic thromboembolic pulmonary hypertension after acute pulmonary embolism.急性肺栓塞后慢性血栓栓塞性肺动脉高压的临床预测评分的推导。
J Thromb Haemost. 2016 Jan;14(1):121-8. doi: 10.1111/jth.13175. Epub 2015 Dec 29.
6
Clinical features and management of chronic thromboembolic pulmonary hypertension in Thai.泰国慢性血栓栓塞性肺动脉高压的临床特征与管理
J Med Assoc Thai. 2010 Jan;93 Suppl 1:S79-85.
7
Chronic Thromboembolic Pulmonary Hypertension.慢性血栓栓塞性肺动脉高压
Lung. 2022 Jun;200(3):283-299. doi: 10.1007/s00408-022-00539-w. Epub 2022 May 29.
8
Evaluation and Management of Chronic Thromboembolic Pulmonary Hypertension.慢性血栓栓塞性肺动脉高压的评估和管理。
Chest. 2023 Aug;164(2):490-502. doi: 10.1016/j.chest.2023.03.029. Epub 2023 Mar 28.
9
Chronic thromboembolic pulmonary hypertension: anticoagulation and beyond.慢性血栓栓塞性肺动脉高压:抗凝及其他。
Hematology Am Soc Hematol Educ Program. 2021 Dec 10;2021(1):478-484. doi: 10.1182/hematology.2021000282.
10
Incidence and risk factors of chronic thromboembolic pulmonary hypertension in patients with diagnosis of pulmonary embolism for the first time in real world.真实世界中首次诊断为肺栓塞患者慢性血栓栓塞性肺动脉高压的发病率及危险因素
Clin Respir J. 2018 Nov;12(11):2551-2558. doi: 10.1111/crj.12955. Epub 2018 Oct 9.

本文引用的文献

1
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.2022年欧洲心脏病学会/欧洲呼吸学会肺动脉高压诊断和治疗指南。
Eur Respir J. 2023 Jan 6;61(1). doi: 10.1183/13993003.00879-2022. Print 2023 Jan.
2
Chronic Thromboembolic Pulmonary Hypertension: An Update.慢性血栓栓塞性肺动脉高压:最新进展
Diagnostics (Basel). 2022 Jan 19;12(2):235. doi: 10.3390/diagnostics12020235.
3
External validation of a refined four-stratum risk assessment score from the French pulmonary hypertension registry.法国肺动脉高压注册研究中一种改良的四分层风险评估评分的外部验证。
Eur Respir J. 2022 Jun 30;59(6). doi: 10.1183/13993003.02419-2021. Print 2022 Jun.
4
Chronic thromboembolic pulmonary hypertension.慢性血栓栓塞性肺动脉高压。
Eur Respir J. 2019 Jan 24;53(1). doi: 10.1183/13993003.01915-2018. Print 2019 Jan.
5
Chronic thromboembolic pulmonary hypertension: an enigma.慢性血栓栓塞性肺动脉高压:一个谜团。
BMJ Case Rep. 2018 Aug 27;2018:bcr-2018-225764. doi: 10.1136/bcr-2018-225764.
6
Long-term survival in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Insights from a referral center in Portugal.肺动脉高压和慢性血栓栓塞性肺动脉高压的长期生存:来自葡萄牙一家转诊中心的见解。
Rev Port Cardiol (Engl Ed). 2018 Sep;37(9):749-757. doi: 10.1016/j.repc.2018.02.009. Epub 2018 Aug 23.
7
Diagnosis of chronic thromboembolic pulmonary hypertension.慢性血栓栓塞性肺动脉高压的诊断
Eur Respir Rev. 2017 Mar 15;26(143). doi: 10.1183/16000617.0108-2016. Print 2017 Jan.
8
Dynamic Risk Stratification of Patient Long-Term Outcome After Pulmonary Endarterectomy: Results From the United Kingdom National Cohort.肺动脉内膜剥脱术后患者长期预后的动态风险分层:来自英国全国队列的结果
Circulation. 2016 May 3;133(18):1761-71. doi: 10.1161/CIRCULATIONAHA.115.019470. Epub 2016 Apr 6.